Asset Management One
TRIB

Asset Management One’s Trinity Biotech TRIB Stock Holding History

Asset Management One’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-15,800
Closed -$1.04M – 1200
2016
Q3 		$1.04M Sell
15,800
-460
-3% -$28.6K 0.02% 835
2016
Q2 		$922K Buy
16,260
+100
+0.6% +$5.64K 0.01% 870
2016
Q1 		$942K Buy
16,160
+2,400
+17% +$127K 0.01% 878
2015
Q4 		$809K Buy
13,760
+480
+4% +$28.3K 0.01% 932
2015
Q3 		$760K Buy
13,280
+2,780
+26% +$224K 0.01% 940
2015
Q2 		$948K Buy
10,500
+2,280
+28% +$197K 0.01% 890
2015
Q1 		$791K Buy
8,220
+5,500
+202% +$508K 0.01% 959
2014
Q4 		$238K Buy
+2,720
New +$234K ﹤0.01% 1166
2013
Q3 		– Sell
-940
Closed -$79K – 1128
2013
Q2 		$79K Buy
+940
New +$78K ﹤0.01% 1021

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Asset Management One's TRIB Position: Q4 2016 in Review

Asset Management One sold out of Trinity Biotech (TRIB) in Q4 2016, closing a stake of 15,800 shares — an estimated $1.04M sold.

Asset Management One first reported a position in TRIB in Q2 2013 and held it in 9 quarters. The position peaked at $1.04M in Q3 2016. 71 funds tracked by Wall St. Rank hold TRIB as of Q4 2016.

  • Asset Management One reported no remaining Trinity Biotech position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 15,800 Trinity Biotech shares in Q4 2016, an estimated $1.04M.
  • Asset Management One first reported a position in Trinity Biotech in Q2 2013 and held it in 9 quarters.
  • Asset Management One's Trinity Biotech position peaked at $1.04M in Q3 2016.
  • 71 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.